Disc Medicine, Inc. SEC filings IRON
Disc Medicine, Inc. has 778 filings in SEC EDGAR's recent list, going back to Jul 2, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| 424B5 | Prospectus supplement | Oct 21, 2026 | — |
| 424B5 | Prospectus supplement | Oct 20, 2026 | — |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 424B5 | Prospectus supplement | Oct 21, 2025 | — |
| 424B5 | Prospectus supplement | Oct 20, 2025 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 424B5 | Prospectus supplement | Jan 23, 2025 | — |
| 424B5 | Prospectus supplement | Jan 21, 2025 | — |
| 424B5 | Prospectus supplement | Nov 15, 2024 | — |
| POS AM | Filing | Nov 15, 2024 | — |
| S-3ASR | Automatic shelf registration | Aug 8, 2024 | — |
| 424B5 | Prospectus supplement | Jun 14, 2024 | — |
| S-8 | Employee stock plan registration | Mar 21, 2024 | — |
| POS AM | Filing | Dec 5, 2023 | — |
| 424B5 | Prospectus supplement | Dec 5, 2023 | — |
| S-3 | Shelf registration | Nov 20, 2023 | — |
| 424B5 | Prospectus supplement | Oct 10, 2023 | — |
| 424B5 | Prospectus supplement | Jun 15, 2023 | — |
| 424B5 | Prospectus supplement | Jun 12, 2023 | — |
| 424B5 | Prospectus supplement | Feb 14, 2023 | — |
| 424B5 | Prospectus supplement | Jan 25, 2023 | — |
| S-3 | Shelf registration | Jan 18, 2023 | — |
| S-8 | Employee stock plan registration | Jan 18, 2023 | — |
| S-3 | Shelf registration | Jan 18, 2023 | — |
| 424B3 | Prospectus | Dec 2, 2022 | — |
| S-4/A | Filing | Dec 1, 2022 | — |
| S-4/A | Filing | Nov 23, 2022 | — |
| S-4/A | Form s-4/a | Nov 3, 2022 | — |
| S-4/A | Filing | Oct 7, 2022 | — |
| S-4 | Registration for a merger or exchange | Sep 2, 2022 | — |
| POS AM | Filing | Mar 11, 2022 | — |
| S-8 | Employee stock plan registration | Mar 10, 2022 | — |
| POS AM | Filing | Mar 10, 2022 | — |
| 424B3 | Prospectus | Feb 28, 2022 | — |
| 424B3 | Prospectus | Jan 14, 2022 | — |
| 424B3 | Prospectus | Jan 10, 2022 | — |
| 424B3 | Prospectus | Nov 15, 2021 | — |
| 424B3 | Prospectus | Nov 12, 2021 | — |
| S-8 | Employee stock plan registration | Oct 14, 2021 | — |
| 424B3 | Prospectus | Oct 6, 2021 | — |
| 424B3 | Prospectus | Oct 1, 2021 | — |
| 424B3 | Prospectus | Sep 9, 2021 | — |
| 424B3 | Prospectus | Aug 17, 2021 | — |
| 424B3 | Prospectus | Aug 12, 2021 | — |
| 424B3 | Prospectus | Jun 23, 2021 | — |
| 424B3 | Prospectus | May 13, 2021 | — |
| 424B3 | Prospectus | May 12, 2021 | — |
| S-8 | Employee stock plan registration | Apr 13, 2021 | — |
| S-1/A | Amended registration statement | Mar 29, 2021 | — |
| S-1 | Registration statement | Feb 17, 2021 | — |
| 424B3 | Prospectus | Jan 19, 2021 | — |
| S-4/A | Registration statement | Jan 19, 2021 | — |
| S-4/A | Registration statement | Jan 15, 2021 | — |
| S-4/A | Amendment no. 3 to form s-4 | Jan 12, 2021 | — |
| S-4/A | Registration statement | Dec 28, 2020 | — |
| S-4/A | Registration statement | Dec 7, 2020 | — |
| S-4 | Registration for a merger or exchange | Nov 2, 2020 | — |
| 424B4 | Prospectus | Aug 13, 2020 | — |
| S-1MEF | Registration statement | Aug 11, 2020 | — |
| S-1/A | Amended registration statement | Aug 7, 2020 | — |
| S-1 | Registration statement | Jul 24, 2020 | — |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IRON (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Watertown, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1816736
- Former names
- Gemini Therapeutics, Inc. /DE (until Dec 28, 2022); FS Development Corp. (until Feb 8, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.